Verification of additional genetic alterations in ccRCC was demonstrated in a mouse model study that combined deletion of Vhl, transformation-related protein 53 (Trp53), and retinoblastoma (Rb1) genes to induce ccRCC development (18). This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.